Cigna 8-K: Officer Compensation Arrangements Updated Jan 16

Ticker: CI · Form: 8-K · Filed: 2024-01-22T00:00:00.000Z

Sentiment: neutral

Topics: compensatory-arrangements, executive-compensation, corporate-governance

TL;DR

**Cigna just updated executive pay arrangements, watch for details on how it impacts future performance.**

AI Summary

The Cigna Group filed an 8-K on January 22, 2024, reporting an event that occurred on January 16, 2024, related to changes in compensatory arrangements for certain officers. This filing indicates potential adjustments to executive pay structures, which could impact the company's financial performance and governance. For investors, understanding these changes is crucial as executive compensation can influence management's incentives and the company's overall cost structure, potentially affecting stock valuation.

Why It Matters

Changes in executive compensation can signal shifts in company strategy or performance incentives, directly impacting shareholder value and corporate governance. Investors should monitor these details for insights into management's alignment with long-term company goals.

Risk Assessment

Risk Level: low — This filing is administrative, reporting changes in compensatory arrangements, which is a routine disclosure and does not inherently indicate high risk without further details on the nature of the changes.

Analyst Insight

Investors should monitor Cigna's upcoming proxy statements and annual reports for detailed disclosures on the specific changes to executive compensatory arrangements, as these can impact long-term shareholder alignment and company performance. This filing is a notification, not a full disclosure of the changes themselves.

Key Numbers

Key Players & Entities

Forward-Looking Statements

FAQ

What was the specific item reported in this 8-K filing by The Cigna Group?

The 8-K filing, dated January 22, 2024, reported an event under Item 5.02, specifically 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers' that occurred on January 16, 2024.

When did the earliest event reported in this 8-K filing take place?

The earliest event reported in this 8-K filing occurred on January 16, 2024, as stated in the 'Date of Report (Date of earliest event reported)' section.

What is the trading symbol and the exchange where The Cigna Group's Common Stock is registered?

The Cigna Group's Common Stock trades under the symbol 'CI' and is registered on the New York Stock Exchange, according to the 'Securities registered pursuant to Section 12(b) of the Act' section.

What is the state of incorporation for The Cigna Group?

The Cigna Group is incorporated in Delaware, as indicated in the 'State or other jurisdiction of incorporation' section of the filing.

What is the business address and phone number of The Cigna Group as listed in the filing?

The business address of The Cigna Group is 900 Cottage Grove Road, Bloomfield, Connecticut 06002, and its telephone number is (860) 226-6000, as detailed in the filing.

From the Filing

0000950159-24-000017.txt : 20240122 0000950159-24-000017.hdr.sgml : 20240122 20240119184004 ACCESSION NUMBER: 0000950159-24-000017 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20240116 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240122 DATE AS OF CHANGE: 20240119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cigna Group CENTRAL INDEX KEY: 0001739940 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 824991898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38769 FILM NUMBER: 24546703 BUSINESS ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 BUSINESS PHONE: 8602266000 MAIL ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 FORMER COMPANY: FORMER CONFORMED NAME: Cigna Corp DATE OF NAME CHANGE: 20181221 FORMER COMPANY: FORMER CONFORMED NAME: Halfmoon Parent, Inc. DATE OF NAME CHANGE: 20180508 8-K 1 cigna8k.htm THE CIGNA GROUP FORM 8-K false 0001739940 0001739940 2024-01-16 2024-01-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES   SECURITIES AND EXCHANGE COMMISSION   Washington, D.C. 20549   FORM  8-K     CURRENT REPORT   Pursuant to Section 13 or 15(d) of the   Securities Exchange Act of 1934   Date of Report (Date of earliest event reported) January 16, 2024   The Cigna Group   (Exact name of registrant as specified in its charter)   Delaware (State or other jurisdiction of incorporation) 001-38769 (Commission File Number) 82-4991898 (IRS Employer Identification No.)   900 Cottage Grove Road Bloomfield , Connecticut 06002   (Address of principal executive offices) (Zip Code)   Registrant’s telephone number, including area code:   ( 860 ) 226-6000   Not Applicable   (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $0.01 CI New York Stock Exchange , Inc.   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).   Emerging growth company  ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.   On January 16, 2024, Mary Agoglia Hoeltzel, Senior Vice President and Chief Accounting Officer, notified The Cigna Group of her intention to retire, effective July 1, 2024.          SIGNATURE   Pursuant to the requirements of th

View on Read The Filing